But new research suggests that herpes simplex virus type 1 (HSV-1), carried silently by billions, may leave a far more ...

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing a total deal value of $470 million.

Event also includes bake sale, with proceeds going to Walk to End Alzheimer's As one of its ways to reach out to the community, Oak Park Place will sponsor its annual Garden Show and Bake Sale on June ...

SANOFI will acquire Vigil Neuroscience, a clinical-stage biotech company in a $470-million deal, the companies said on Thursday, as the French drugmaker seeks to boost its neurological pipeline ...

Vigil Neuroscience shares jumped nearly 250% Thursday after the Alzheimer's disease drug developer reached a deal to be ...

Burruss’ aunt is part of the beloved “Old Lady Gang.” In addition to Jones, the trio — which earned the nickname "Old Lady ...

The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and ...

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...

While AD is characterized by short-term memory decline, early-onset AD – which accounts for about 5% of AD cases – tends to ...

See the full list of federal grants cut by the Trump administration across University of Tennessee System campuses, including 28 in Knoxville.

More than a billion people around the world suffer from mental disorders such as Alzheimer’s, Parkinson’s, ALS, Huntington’s, ...

Discover why reducing sedentary behavior may be more crucial than exercise in preventing Alzheimer's, and learn simple daily ...